Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D1/00—Evaporating
  • B01D1/16—Evaporating by spraying
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
  • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
  • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D1/00—Evaporating
  • B01D1/16—Evaporating by spraying
  • B01D1/18—Evaporating by spraying to obtain dry solids

Definitions

• This invention generally relates to spray dryers and more particularly to methods and equipment for drying particles produced by spray drying.
• Spray drying is commonly used in the production of particles for many applications, including food, cosmetics, fertilizers, dyes, and abrasives.
• Spray drying can be tailored to create a wide spectrum of particle sizes, including microparticles.
• Spray dried particles are useful in a variety of biomedical and pharmaceutical applications, such as the delivery of therapeutic and diagnostic agents, as described for example in U.S. Patent No. 5,853,698 to Straub et al, U.S. Patent No. 5,855,913 to Hanes et al, and U.S. Patent No. 5,622,657 to Takada et al.
• a solid forming material such as a polymer, which is intended to form the bulk of the particle, is dissolved in an appropriate solvent to form a solution.
• the material can be suspended or emulsified in a non-solvent to form a suspension or emulsion.
• Other components such as drugs, diagnostic agents, or pore forming agents, optionally are added at this stage.
• the solution then is atomized to form a fine mist of droplets.
• the droplets immediately enter a drying chamber where they contact a drying gas.
• the solvent is evaporated from the droplets into the drying gas to solidify the droplets, thereby forming particles.
• the particles then are separated from the drying gas and collected.
• the change in drying rate may, for instance, alter the way in which the solid-forming material precipitates as the solvent is evaporated, thereby changing the structure (e.g., porosity) of the particle to be out of specification, rendering the particle unable to properly contain and deliver a diagnostic or therapeutic agent.
• changing the drying rate by reducing the flowrate (and consequently the velocity) of the drying gas may substantially reduce the product yield.
• drying efficiency may require undesirably large increases in the size of process equipment, such as the drying chamber, drying gas source, and drying gas heater.
• the drying capacity generally is a function of the drying gas temperature, flowrate, pressure, and solvent composition.
• larger capacity equipment generally requires more plant space. It is desirable to minimize the capital investment and space required to scale up a production process.
• Inadequate product drying can also be a problem with known spray drying processes, particularly for some pharmaceutical products which must be dried at low temperatures in order to maintain the stability and/or activity of these materials. Further drying of these materials sensitive to high temperatures can be done using a fluidized bed; however, this process often results in undesirably variable process yields.
• Known spray dryers typically are unsuitable for aseptic processing, as they may operate at negative pressure, for example, and may not be designed or constructed to comply with regulatory requirements. In particular, they do not provide a way to completely dry the material aseptically in a sanitizable, closed, and positive-pressure system.
• particles are formed by spraying a solution (or emulsion or solid-in-liquid suspension) of a material into a primary drying chamber and evaporating at least a portion of the solvent (or nonsolvent liquid) sufficient to solidify the particles.
• the solvent (or nonsolvent) is evaporated into the drying gas in which the particles are entrained.
• the secondary drying apparatus increases the drying efficiency of the spray dryer system without increasing the drying rate, while minimizing loss in yield.
• the secondary drying apparatus includes tubing having a length sufficient to increase the contact time between the drying gas and the particles (i.e. increase the residence time) to dry the particles to the extent desired, at a drying capacity or drying rate and temperature which would be too low to provide adequate drying using only the primary drying chamber.
• the ratio of the length of tubing to the length of the primary drying chamber is at least 2:1, and more preferably at least 3:1.
• the tubing cross-sectional area is substantially smaller than the cross-sectional area of the primary drying chamber, such that the particles move at higher velocity through the tubing to minimize product losses.
• the ratio of the cross-sectional area of the primary drying chamber to the cross-sectional area of the tubing preferably is between about 2: 1 and 500: 1 , more preferably is between about 4:1 and 100:1, and most preferably is about 16:1.
• the tubing is stainless steel, and electropolished to 20 RA or smoother, to provide a smooth surface for enhanced particle yield.
• the tubing preferably is in a compact coil design, for easier transporting and which has minimum space requirements.
• the tubing has a jacket to control the temperature of the secondary drying process.
• the primary drying chamber and secondary apparatus can be integrated into a single unit.
• a preferred application for the spray drying process and equipment is in the production of particles between about 1 and 200 ⁇ m in diameter, which can be used in the delivery of a diagnostic or therapeutic agent.
• Figure 1 is a process equipment diagram of a preferred embodiment of the secondary drying apparatus integrated into a process for making and collecting spray dried particles.
• Improved spray drying methods and equipment have been developed.
• the improved process design enhances drying of spray dried particles prior to collection by increasing the time the particles contact the drying gas, preferably without increasing the drying rate or reducing the product yield.
• the increased residence time is accomplished by use of a secondary drying apparatus.
• drying in reference to droplets or particles means the removal of the solvent from the droplet or particle.
• Drying capacity refers to the theoretical maximum quantity of liquid volatiles that can be evaporated into the drying gas. For example, if the drying capacity is met, the drying gas stream will be fully saturated with the volatiles.
• the drying capacity parameter is dependent on the drying gas flowrate, temperature, pressure, and volatile composition.
• Drying efficiency refers to the quantity of evaporated liquid volatiles divided by the drying capacity for a given set of process parameters. The drying efficiency parameter depends on the solution flowrate, drying gas flowrate, temperature, pressure, and volatile composition, as well as the geometry of the drying chamber and the residence time of the material being dried.
• Drying rate refers to the quantity of liquid volatiles evaporating from the surface of atomized droplets as a function of time.
• the drying rate is a function of particle size, composition, and morphology; drying gas temperature, pressure, and flowrate; solution flowrate; drying gas humidity; and particle position along the drying path length.
• solvent refers to the liquid in which the material forming the bulk of the spray dried particle is dissolved, suspended, or emulsified for delivery to the atomizer of a spray dryer and which is evaporated into the drying gas, whether or not the liquid is a solvent or nonsolvent for the material.
• Other volatilizable components such as a volatile salt, may be included in the bulk material/liquid, and also volatilized into the drying gas. Examples of volatile salts, which are useful pore- forming agents, include ammonium biocarbonate, ammonium acetate, ammonium chloride, and ammonium benzoate.
• the particles made by spray drying processes can be of any size.
• the term "particle” includes micro-, submicro-, and macro- particles. Generally, the particles are between about 100 nm and 5 mm in diameter or longest dimension.
• the particles can be spheres, capsules, irregular shapes, crystals, powders, agglomerates, or aggregates.
• the particles can be hollow, that is they can have an outer shell surrounding a core of gas, such as a diagnostic agent, or they can be formed having pores through the solid material, yielding a honeycombed or sponged structure.
• the particles can be generally solid, that is they can be homogeneous throughout or they can include smaller solid particulates of diagnostic or therapeutic agent dispersed throughout the solid material of each particle.
• the secondary drying apparatus 10 includes a coil of tubing which forms the drying coil 11, having drying coil inlet 12 and drying coil outlet 13.
• the drying coil 11 is surrounded by a drying coil jacket 16.
• Thejacket 16 includes a jacket inlet 14 and a jacket drain 15.
• Thejacket inlet 14 and jacket drain 15 provide a means for a heat exchange medium, such as cooling water, to flow respectively into and out of the drying coil jacket 16.
• the drying coil jacket 16 is based on standard designs known in the heat exchanger art.
• the "primary drying chamber” is defined to be the vessel into which the atomized material and solvent is sprayed from the atomizer.
• the primary drying chamber has an internal flow space terminating in a discharge outlet.
• the "discharge outlet" of the primary drying chamber is defined to be the area in which flowing drying gas/particles initially encounter a reduction in the flow cross-sectional area of at least 25% (i.e. the point at which the ratio of the cross-sectional area of the primary drying chamber to the cross-sectional area of the tubing is at least 4:3).
• the "length of the primary drying chamber” is defined to be the approximate minimum distance a droplet/particle must travel from the atomizer to reach the discharge outlet.
• atomizer refers to any atomization device.
• Representative atomizers include pressure nozzles, pneumatic nozzles, sonic nozzles, and rotary atomizers. Examples of suitable rotary atomizers include bushing wheels, vaned wheels, and vaneless discs.
• Pressure nozzles include swirled chamber and grooved core types.
• Pneumatic nozzles include two fluid (internal and external mixing) and three fluid types. Sonic nozzles include siren and whistle types.
• tubing refers to a pipe or other conduit having at least one inlet and at least one outlet.
• the cross-section of the tubing can be of any shape; circular is preferred.
• the tubing can be formed into any configuration. For example, it can be straight, serpentine, or coiled. Portions of the tubing can be stacked in connected layers, as commonly found in heat exchanger applications.
• the coil can be polygonal, circular, or a combination thereof. In a preferred embodiment, a circular coiled design is used, since it provides a compact design and is generally free of sharp bends in the flow path, which can provide unwanted points of particle impact and accumulation.
• Tubing Dimensions The tubing must have a pathway length long enough to provide sufficient contact time (i.e.
• the term "length" used in reference to the tubing refers to the approximate minimum distance a droplet/particle must travel from the inlet to reach the outlet. At a given velocity, the minimum length required to provide the necessary residence time for a given set of process conditions and materials may have to be obtained empirically.
• a series of tubes of increasing length can be used in a series of spray drying tests run at constant flow rate and temperature, followed by measuring the moisture (i.e. the solvent residue) remaining in the product particles. One can then plot the moisture versus tube length to obtain a length-moisture curve. From this curve, one can extrapolate to obtain the minimum length required to obtain a particular moisture level for the set drying rate and drying gas velocity.
• the velocity of the drying gas has been found to be critical to the production yield of the particles. For example, too low a velocity can cause particles to settle out of the gas stream. Too low of a velocity also can increase aggregation of material along the vessel wall due to (1) cohesion if particles are inadequately dry and have a tacky surface, (2) electrostatic forces due to static build up on well-dried particles, and/or (3) mechanical entrapment, for example, in cracks at piping joints or in microcracks in inadequately polished piping surfaces.
• drying gas velocity in the primary drying chamber is between about 0.1 and 100 m/s. In a preferred embodiment, the drying gas velocity in the primary drying chamber is between about 0.5 and 5 m/s.
• the length of the tubing is at least twice the length of the primary drying chamber. More preferably, this tubing length to primary drying chamber ratio is greater than 3:1.
• the diameter of the tubing of the second drying apparatus is only slightly less than the diameter of the primary drying chamber, for example, having a reduction ratio (primary drying chamber cross-sectional area:tubing cross-sectional area) between 4:3 and 2: 1.
• the diameter of the tubing is significantly smaller than the diameter of the primary drying chamber, thereby increasing the particle and gas velocity in the tubing compared to their velocity in the primary drying chamber in order to maximize product yield.
• the reduction ratio is preferably between 2: 1 and 500: 1. more preferably between about 4:1 and 100:1, and most preferably about 16:1.
• the cross-sectional area of the tubing can be constant over, or can vary along, the length of the tubing.
• one or more reducers or expanders
• the cross-sectional area is substantially uniform along the length of the tubing.
• the tubing can be formed of, or lined with, any material of sufficient structural integrity that is compatible with the spray dried particles.
• the tubing should be resistant to corrosion and crack damage. If jacketed, the tubing material should be compatible with the heat exchange medium selected.
• Representative materials include glasses, polymers, metals, and composites thereof. Examples of suitable metals include copper, aluminum, iron, brass, nickel, and steel.
• Polymeric materials generally should be properly grounded to prevent static charge build-up, which can cause particle accumulation and can otherwise be hazardous. Examples of suitable polymeric materials include polyvinylchloride and polytetrafluoroethylene (TEFLONTM). The materials of construction are particularly important for particles intended for use in biomedical applications, where purity is essential.
• the tubing is medical grade stainless steel.
• the surface roughness of the inside of the tubing generally is a design consideration. A rough surface may reduce the yield and create problems with product purity in some applications, especially pharmaceutical grade products.
• the tubing preferably has a Roughness Average (RA) of 50 or smoother, and more preferably 20 or smoother. Standard electropolishing techniques can be used, for example, on stainless steel tubing to achieve these roughness levels.
• the spray drying apparatus and system is designed and constructed to operate in a sterile or aseptic manner in order to produce sterile particles, particularly particles for medical or pharmaceutical products. It is preferred that the sterility can be certified or validated using known techniques.
• the apparatus can be made using techniques, equipment, and materials known in the art, and should be, for example, resistant to steam, heat, ionizing radiation, and/or sterilizing chemical vapors such as ethylene oxide, volatile peroxides and ozone. Couplings between sections of the apparatus should be selected to maintain the sterile conditions. Examples include TRICLOVERTM or equivalent flanges and gaskets.
• the design and arrangement of the spray drying apparatus also should prevent, or at least minimize, powder accumulating within the apparatus or system except where intended (e.g., in a collector such as a cyclone).
• the secondary dryer preferably is positioned to provide a constant downward slope from the primary chamber to the collection device. Additional gas feeds, preferably at a controlled temperature and sterile, can be provided at any point in the spray drying apparatus or system to facilitate particle transport and prevent unwanted accumulation throughout the entire apparatus to the collection point.
• FIG. 1 A preferred method of using the secondary drying apparatus is described with reference to Figure 1 , wherein the secondary drying apparatus 10 is part of a spray drying process that includes a primary drying chamber 20, a product cyclone 30, and a product collection container 31. While Figure 1 shows a co-current vertical downward flow spray dryer having a conical bottom, the methods and apparatus described herein are adaptable to essentially any type of spray dryer, including cross-current, mixed, or spiral flow dryers, having horizontal, vertical-up, or vertical-down flows.
• the primary drying chamber generally can be of any shape, including cylindrical, conical, or parallelepiped.
• a product solution (C) is sprayed or atomized into primary drying chamber 20 through a nozzle 26.
• the drying gas (A) enters through the drying gas feed inlet 23, passes through drying gas heater 27, and then flows through drying gas filter 24 to remove dust and other fine particulate matter.
• the drying gas then enters the primary drying chamber 20 through drying gas inlet 25.
• Atomization gas (B) is supplied to nozzle 26 through atomization gas line 28 and fed through atomizer 26 into the primary drying chamber 20.
• the drying gas flow to drying gas feed inlet 23 can be induced by a variety of gas generating and/or transfer devices, such as a fan, blower, compressor, or liquefied gas evaporator.
• the gas source can be atmospheric air or a dedicated source of compressed gas or liquefied gas, stored for example in pressurized tanks.
• the drying gas is nitrogen, which is generated from a liquid nitrogen vaporizer, wherein the tank or vaporizer pressure provides the driving force.
• the atomized droplets solidify into particles as they contact and are entrained in the cocurrent drying gas flow. Oversized particles are collected in collection jar 22. The remaining particles exit through primary drying chamber discharge outlet 29 and flow to secondary drying apparatus 10, where the particles pass through drying coil 11 via inlet 12 and outlet 13. The sufficiently dried particles then enter product cyclone 30 through product cyclone inlet 32. In product cyclone 30, the particles are separated from the drying gas (D), which is exhausted through product cyclone outlet 33. The dried particles are collected in product collection container 31.
• Representative heat exchange media include water (liquid and steam), acetone, air, brine, d'limonene, ethanol, ethylene glycol, freons, isopropanol, nitrogen (gaseous and liquid), methanol, propylene glycol, silicon oil, and sulfur hexafluoride.
• Temperature control may be particularly important for maintaining the stability of product particles which are formed or contain highly temperature sensitive substances, such as thermally labile drugs (including but not limited to proteins, peptides, vaccines, and nucleic acids) while simultaneously maximizing the drying efficiency.
• the spray drying methods and equipment can be adapted for use in either a continuous or batch process.
• the temperature of the inlet and outlet ports can be controlled to produce the desired products, and may be varied depending on the gas, solvent, and solid material used.
• the size of the particles of polymer solution is a function of the atomizer used to spray the polymer solution, the atomizer pressure, the flow rate, the polymer used, the polymer concentration, the type of solvent, the viscosity, the temperature of spraying (both inlet and outlet temperature), and the molecular weight of the polymer. Generally, the higher the molecular weight, the larger the particle size, assuming the concentration is the same.
• inlet temperature 30 to 400 °C
• outlet temperature 6 to 100 °C
• emulsion/solution/suspension flow rate 5 to 5000 ml/min
• nozzle diameter 0.2 to 4 mm ID.
• polymer concentration in the emulsion/solution/suspension typically is 0.001 to 0.75 g/ml
• drug concentration in the emulsion/solution/suspension also typically is 0.001 to 0.75 g/ml.
• the particle morphology depends on the several factors, including the selection of polymer and/or therapeutic agent, as well as the concentration, molecular weight, and flow rates of materials.
• typical outlet temperatures are between about 70 and 400 °C.
• Masters, "Spray Drying Handbook" pp. 498-511 (5 th ed., John Wiley & Sons 1991) describes typical plant design and spray drying conditions for a variety of materials. These designs and conditions can be adapted for use with the methods described herein.
• the inlet temperature can be less than 100 °C, preferably less than 60 °C, and more preferably less than 40 °C.
• the outlet temperature typically is equal to or less than the inlet temperature and thus can be less than 100 °C, preferably less than 60 °C, and more preferably less than 40 °C.
• temperatures cooler than 40 °C are possible and preferable.
• outlet temperatures of 25 °C or less, preferably 12 °C or less are desirable, for example, for materials with low melting or degradation points.
• the secondary drying apparatus and methods described herein can be used in, or adapted to, a variety of spray drying processes to make particles in various industries, including abrasives, agricultural products, biochemical products, chemicals, cosmetics, dyes, foods, metals (e.g. abrasives), pigments, and pharmaceuticals.
• Representative pharmaceutical and biochemical products and product classes include proteins, peptides, and nucleic acids, as well as antibiotics, enzymes, vitamins, yeasts, sera, vaccines, plasma-derived products, hormones, mycelia, and amino acids.
• acyrlonitrile butadiene styrene ABS
• acrylic resin alumina
• aluminum sulfate aluminum sulfate
• zinc and nickel catalysts graphite
• iron oxide iron oxide
• polyvinyl acetate polyvinyl chloride
• silica gel sodium aluminate, titanium dioxide, and zinc phosphate.
• the spray drying apparatus is used to form particles of a therapeutic agent, which optionally can include one or more excipients.
• the therapeutic agent can be a small molecule drug or a larger molecule drug (e.g., peptide or protein), such as insulin, growth hormones, erythropoietin, or interferon.
• the particles are formed of a bulk or matrix material having the therapeutic agent dispersed throughout the material, for use in controlled drug delivery.
• the secondary drying apparatus preferably is used in a process to make particles having a diameter between about 100 nm and 5 mm, more preferably between about 1 and 200 ⁇ m.
• the spray drying methods and equipment are adapted to make the microparticles as described in U.S. Patent No. 5,853,698 to Straub et al..
• the polymers that can be used in the methods and equipment described herein include synthetic and natural polymers, non-biodegradable and biodegradable polymers, and water-soluble and water-insoluble polymers.
• Representative synthetic polymers include poly(hydroxy acids) such as poly(lactic acid), poly(glycolic acid), and poly(lactic acid-co-glycolic acid), polyglycolides, polylactides, polylactide co-glycolide copolymers and blends, polyanhydrides, polyorthoesters, polyamides, polycarbonates, polyalkylenes such as polyethylene and polypropylene, polyalkylene glycols such as poly(ethylene glycol), polyalkylene oxides such as poly(ethylene oxide), polyalkylene terepthalates such as poly(ethylene terephthalate), polyvinyl alcohols, polyvinyl ethers, polyvinyl esters, polyvinyl halides such as poly(vinyl chloride), polyvinylpyrrolidone, polysilox
• derivatives include polymers having substitutions, additions of chemical groups, for example, alkyl, alkylene, hydroxylations, oxidations, and other modifications routinely made by those skilled in the art.
• non-biodegradable polymers include ethylene vinyl acetate, poly(meth)acrylic acid, polyamides, copolymers and mixtures thereof.
• biodegradable polymers examples include polymers of hydroxy acids such as lactic acid and glycolic acid, polylactide, polyglycolide, polylactide co glycolide, and copolymers with PEG, polyanhydrides, poly(ortho)esters, polyurethanes, poly(butyric acid), poly(valeric acid), and poly(lactide-co-caprolactone).
• Representative natural polymers include proteins and polysaccharides.
• the choice of solvent depends on the bulk material and the form of the material fed to the atomizer, e.g., whether the material is to be dissolved, suspended, or emulsified in the solvent.
• the solvent is an organic solvent that is volatile or has a relatively low boiling point or can be removed under vacuum and which is acceptable for administration to humans in trace amounts.
• Representative solvents include acetic acid, acetaldehyde dimethyl acetal, acetone, acetonitrile, butynol, chloroform, chlorofluorocarbons, dichloromethane, dipropyl ether, diisopropyl ether, N,N-dimethlyformamide (DMF), demethyl sulfoxide (DMSO), dioxane, ethanol, ethyl acetate, ethyl formate, ethyl vinyl ether, glycerol, heptane, hexane, isopropanol, methanol, methylene chloride, nitromethane, octane, pentane, tetrahydrofuran (THF), toluene, 1,1,1-trichloroethane, 1,1,2-trichloroethylene, water, xylene, and combinations thereof.
• DMF N,N-dimethlyformamide
• the polymer is dissolved in the solvent to form a polymer solution having a concentration of between 0.1 and 75% weight to volume (w/v), more preferably between 0.5 and 30% (w/v).
• w/v weight to volume
• w/v weight to volume
• w/v weight to volume
• w/v weight to volume
• Three identical polymer emulsions were prepared, each composed of droplets of an aqueous phase suspended in a continuous polymer/organic solvent phase.
• the polymer was poly(lactide-co-glycolide) (PLGA) (50:50, MW approximately 35,000 Da) and the organic solvent was methylene chloride.
• the emulsions were sprayed through identical nozzles under identical process conditions of emulsion flow rate, atomization rate, drying gas rate, drying gas inlet temperature, and drying gas outlet temperature. Each emulsion was sprayed into a 6" (15.24 cm) diameter primary drying chamber ("PDC").
• PDC primary drying chamber
• SDA secondary drying apparati
• the coil system produced the highest yield (72%) and the lowest moisture (6.86%) of the three systems evaluated.
• Table 1 the residence times and drying capacities of the three systems are not identical, which probably accounts for at least some of the variation in measured moisture content.
• the variation in yield is more striking, since if one were to increase the lengths of the 4" (10.16 cm) and 6" (15.24 cm) secondary chambers to provide a volume identical to that of the coils, the yield for the 4" (10.16 cm) and 6" (15.24 cm) secondary chamber systems would be even less than that of the coil system.
• the yield difference is most likely due to the comparatively lower drying gas velocity in the 4" (10.16 cm) and 6" (15.24 cm) secondary chambers.
• Example 2 Comparison of Secondary Drying Apparati
• Four identical polymer emulsions were prepared, each composed of an aqueous phase suspended in a continuous phase of polymer dissolved in an organic solvent.
• the emulsions were spray dried through identical nozzles under identical process conditions of emulsion flow rate, atomization rate, drying gas rate, drying gas inlet temperature, and drying gas outlet temperature.
• Each emulsion was sprayed into the same primary drying chamber, which had a diameter of 6" (15.24 cm) and a length of 18" (45.72 cm), for a total volume of 509 in 3 (8340 cm 3 ).
• the moisture content of 28.6% obtained when the primary drying chamber was used without the secondary drying apparatus was undesirably high.
• the results show that the use of a secondary drying apparatus reduced the moisture content by approximately 55% and also reduced the mean particle size slightly.
• the size and moisture content obtained with the secondary drying apparatus were approximately the same for all configurations, which is expected since the emulsions were sprayed under identical process conditions and since each secondary drying apparatus had essentially the same total volume and residence time.
• the spray drying apparatus described in Example 1 was used to make and dry particles of poly(lactide-co-glycolide) (PLGA) (50:50, MW approximately 35,000 Da) using low processing temperatures.
• the primary drying chamber had a length of 19 inches (48.26 cm) and a diameter of 6 inches (15.24 cm), and the secondary drying apparatus had a diameter of 1.5 inches (3.81 cm) and a length of 100 feet (30.5 m).
• the PLGA was dissolved in methylene chloride to form approximately 29 L (liters) of a 3% (w/w) PLGA solution.
• the polymer solution then was emulsified with 2 L of an aqueous solution of 18% ammonium bicarbonate in a 75 liter mixing tank fitted with an Admix Rotosolver homogenizer (Model 100RS88SS) by homogenizing for 6.5 minutes at 3450 RPM.
• Admix Rotosolver homogenizer Model 100RS88SS
• the emulsion was sprayed at a flow rate of 150 ml/min. and aerosolized with nitrogen at a flow rate of 115 liter/min. in an internal- mixing air-atomizing nozzle. Drying gas (nitrogen) was heated to an inlet temperature of 55 °C and introduced into the drying chamber at a flow rate of 105 kg/hr. The drying gas outlet temperature was found to be 12 °C.
• the partially dried particles (exiting the primary drying chamber) were passed through the secondary drying apparatus, which was jacketed with water at 18
• the overall yield of particles collected was 91%.
• the particles had a size distribution characterized by a number-average (X n ) diameter of 2.0 ⁇ m and a volume-average diameter (X v ) of 5.3 ⁇ m, as determined in a Coulter counter.
• the moisture content was 5.18% (w/w).
• the low moisture content was achieved using drying gas temperatures significantly lower than standard practice in current spray drying systems.
• Example 4 Making PEG Microparticles at Low Temperatures The process described in Example 3 was repeated, except for the following parameters: (1) polyethylene glycol (PEG) (MW 8000) was used in place of PLGA; (2) the primary chamber length was 25 inches (63.5 cm);
• the homogenization time was 10 minutes; (4) the drying gas flow rate was 150 kg/hr; and (5) the flow rate of polymer emulsion to the spray nozzle was 200 ml/min.
• the overall yield of free-flowing particles collected was 96%.
• the low temperature processing allowed the preparation of particles of PEG, which might otherwise melt or fuse together during processing, as the melting temperature of PEG (MW 8000) is typically between about 55 and 65 °C. Examples 3 and 4 thus demonstrate that both the inlet and outlet drying gas temperatures can be lowered using the spray drying devices and methods described herein as compared to those temperatures typically used in conventional spray drying.

Landscapes

• Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Medicinal Preparation (AREA)
• Drying Of Solid Materials (AREA)
• Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
• Medical Preparation Storing Or Oral Administration Devices (AREA)
• Glanulating (AREA)

Priority Applications (11)

Applications Claiming Priority (2)

Publications (1)

Family

ID=23175745

Family Applications (1)

Country Status (19)

Cited By (9)

Families Citing this family (85)

Citations (5)

Family Cites Families (19)

• 1999
  • 1999-05-03 US US09/304,257 patent/US6223455B1/en not_active Expired - Lifetime
• 2000
  • 2000-04-26 DK DK00928391T patent/DK1175257T4/da active
  • 2000-04-26 IL IL14626500A patent/IL146265A0/xx not_active IP Right Cessation
  • 2000-04-26 EP EP00928391A patent/EP1175257B9/en not_active Expired - Lifetime
  • 2000-04-26 CA CA002372194A patent/CA2372194C/en not_active Expired - Lifetime
  • 2000-04-26 AU AU46640/00A patent/AU769298B2/en not_active Ceased
  • 2000-04-26 ES ES00928391T patent/ES2216889T5/es not_active Expired - Lifetime
  • 2000-04-26 AT AT00928391T patent/ATE260707T1/de active
  • 2000-04-26 DE DE60008720T patent/DE60008720T3/de not_active Expired - Lifetime
  • 2000-04-26 NZ NZ515684A patent/NZ515684A/en not_active IP Right Cessation
  • 2000-04-26 PT PT00928391T patent/PT1175257E/pt unknown
  • 2000-04-26 JP JP2000615133A patent/JP5412022B2/ja not_active Expired - Fee Related
  • 2000-04-26 KR KR10-2001-7013974A patent/KR100464065B1/ko not_active Expired - Fee Related
  • 2000-04-26 WO PCT/US2000/011158 patent/WO2000066256A1/en not_active Ceased
  • 2000-04-26 BR BRPI0011226-7A patent/BR0011226B1/pt not_active IP Right Cessation
  • 2000-05-03 MY MYPI20001901A patent/MY125075A/en unknown
  • 2000-07-13 TW TW089108409A patent/TW553770B/zh not_active IP Right Cessation
• 2001
  • 2001-01-09 US US09/756,950 patent/US6308434B1/en not_active Expired - Lifetime
  • 2001-11-01 NO NO20015351A patent/NO321912B1/no not_active IP Right Cessation
  • 2001-11-20 ZA ZA200109553A patent/ZA200109553B/en unknown

Patent Citations (5)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events